AMY WHEELER: Open Payments
NPI 1013253103 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 59 payments from 13 companies in 2025. Trend: 2023 $287 · 2024 $1,314 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $271 |
| Madrigal Pharmaceuticals | 11 | $212 |
| Janssen Biotech, Inc. | 5 | $212 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Gilead Sciences, Inc. | 4 | $87 |
| Ardelyx, Inc. | 4 | $77 |
| QOL Medical, LLC | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| GENZYME CORPORATION | 2 | $34 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, LINZESS, IBSRELA, ENTYVIO, MAVYRET, Sucraid.
Industry payments across GA — which companies pay providers there.
